Entera Bio Ltd.
ENTX
$2.89
$0.020.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -108.62% | -16.21% | 5.75% | -20.48% | -3.47% |
| Total Depreciation and Amortization | 28.57% | 0.00% | -12.50% | 14.29% | -12.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 417.26% | -9.60% | -16.76% | 69.68% | -11.50% |
| Change in Net Operating Assets | 222.96% | -163.38% | 301.90% | -143.33% | -12.25% |
| Cash from Operations | -12.10% | -68.58% | 26.74% | -53.40% | -16.17% |
| Capital Expenditure | -- | -- | 37.21% | -48.28% | -262.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 37.21% | -48.28% | -262.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7,692.31% | -25.29% | -30.68% | 945.83% | -99.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 98.67% | 59.68% |
| Cash from Financing | 7,560.77% | -25.29% | -30.40% | 590.20% | -100.38% |
| Foreign Exchange rate Adjustments | 325.00% | -42.86% | -75.86% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 320.20% | -76.06% | 25.90% | -32.44% | -114.35% |